Similar Articles
471 Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
472 Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling
473 Comment on “Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis”
474 Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma
475 Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
476 Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication
477 Risk of hepatocellular carcinoma after hepatitis C virus cure
478 Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma
479 Photodynamic therapy: A next alternative treatment strategy for hepatocellular carcinoma?
480 Neoadjuvant treatment strategies for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA